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LL5: a regulator of postsynaptic differentiation
identified in a screen for synaptically enriched
transcripts at the neuromuscular junction
Masashi Kishi, Terrance T. Kummer, Stephen J. Eglen, and Joshua R. Sanes
Department of Anatomy and Neurobiology, Washington University Medical Center, St. Louis, MO 63110

synaptic sites. LL5 is itself associated with the cytoplasmic
face of the postsynaptic membrane; its highest levels
border regions of highest acetylcholine receptor (AChR)
density, which suggests a role in “corraling” AChRs.
Consistent with this idea, perturbing LL5 expression in
myotubes inhibits AChR aggregation. Thus, a strategy
designed to identify novel synaptic components led to
identification of a protein required for assembly of the
postsynaptic apparatus.

Introduction
A cardinal feature of the chemical synapse is the existence of a
highly specialized postsynaptic apparatus whose molecular
architecture differs dramatically from that of contiguous, nonsynaptic portions of the cell surface (Sanes and Lichtman,
2001; Sheng and Kim, 2002). To understand synaptic development, function, and plasticity, it is important to identify
components of the postsynaptic apparatus, learn how their
distribution is regulated, and determine the roles they play.
A key advance in addressing these issues was the discovery
that some postsynaptic proteins are synthesized locally rather
than (or in addition to) being synthesized at a distant site and
then transported to the synapse. In forebrain neurons, for example,
most protein synthesis occurs in the cell body but specific
subsets of mRNAs are transported to dendritic spines, where
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they are translated (Steward, 1983; for reviews see Steward
and Schuman, 2001; Martin and Kosik, 2002). Likewise, at
the skeletal neuromuscular junction (NMJ), RNAs encoding
some postsynaptic proteins are concentrated and translated
directly beneath the postsynaptic membrane (Merlie and Sanes,
1985; Goldman and Staple, 1989; Jasmin et al., 1993, Moscoso
et al., 1995b; Valenzuela et al., 1995; Imaizumi-Scherrer et
al., 1996; for reviews see Sanes and Lichtman, 1999, 2001;
Chakkalakal and Jasmin, 2003). The mechanism that underlies
localized protein synthesis at the NMJ differs from that in
neurons: RNA localization in muscle results, at least in part,
from transcriptional specialization of the few myonuclei within
the multinucleated muscle fiber that lie beneath the postsynaptic
membrane (Klarsfeld et al., 1991; Sanes et al., 1991; Simon et
al., 1992; for review see Schaeffer et al., 2001). The outcome
is similar in neurons and muscles, however, in that specific
mRNAs are localized to the postsynaptic apparatus.
Identification of these synaptic RNAs provides a means
of identifying proteins likely to be important for synapse
formation or function. Moreover, determining which synaptic
components are synthesized locally is an important step in
understanding how synapse assembly is regulated. In the first
part of this paper, we report results of an expression-profiling
screen designed to identify synaptically enriched RNAs in
muscle. We used the elegant methods of Tietjen et al. (2003) to
amplify RNAs from microdissected NMJs and to compare them
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n both neurons and muscle fibers, specific mRNAs are
concentrated beneath and locally translated at synaptic
sites. At the skeletal neuromuscular junction, all synaptic
RNAs identified to date encode synaptic components.
Using microarrays, we compared RNAs in synapse-rich
and -free regions of muscles, thereby identifying transcripts that are enriched near synapses and that encode
soluble membrane and nuclear proteins. One gene product,
LL5, binds to both phosphoinositides and a cytoskeletal
protein, filamin, one form of which is concentrated at
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Results
A screen for RNAs at synaptic sites

Our aim was to identify polyA RNAs selectively associated
with the postsynaptic apparatus at the NMJ. In previous studies, we and others took advantage of the fact that most synapses
in mammalian muscles are confined to a central “endplate
band” (Fig. 1 A), so that synapse-rich and -free samples can be
generated by cutting the muscle into thirds, perpendicular to
the long axis of the fibers (Hall, 1973; Merlie and Sanes, 1985;
Velleca et al., 1994). However, this strategy is not useful for
global comparisons of gene expression because the NMJ occupies only 0.1% of each muscle fiber’s surface, so synapses
comprise only a small fraction of the nominally synapse-rich
third. Transcripts that are only severalfold enriched at synapses
or that are present at low abundance are not efficiently detected
in this comparison.
We combined two methods to circumvent this problem.
First, we labeled live diaphragm muscles with rhodamine-bungarotoxin (rBTX) to visualize the AChRs concentrated
at synaptic sites and microdissected small groups of closely
spaced NMJs (Fig. 1, B and C). In parallel, we dissected regions of equivalent size from completely synapse-free regions
of the same muscles. The extent to which the dissection enriched synaptic samples can be estimated from counts of nuclei. In mouse diaphragm, about half of all nuclei are within
muscle fibers; the others are in satellite cells, fibroblasts, capillary endothelial cells, and Schwann cells. Each muscle fiber
contains 500 nuclei, of which approximately five are synapse
associated (Merlie and Sanes, 1985). Thus, in the central third
of the muscle, 1.5% (5/[1/3  1000]) of all nuclei are synaptic myonuclei. In the synaptic sample in Fig. 1 (C and D) there
were 21 NMJs and 198 nuclei, so 50% of nuclei were synaptic, a 30-fold improvement over the previous method.
Second, we used the amplification method of Tietjen et
al. (2003) to prepare targets for hybridization to microarrays.
After amplification, sample quality was assessed by Southern
356
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Figure 1. Isolation of synaptic and nonsynaptic samples from muscle.
(A) Diaphragm muscle stained with rBTX and viewed under a fluorescence
dissecting microscope. Fibers run from top to bottom. NMJs are in a central
“endplate band.” (B) Higher-magnification view of the endplate band
shows that small groups of NMJs are tightly clustered. Synaptic samples for
microarray analysis were obtained by microdissecting groups such as the
one boxed in A and B. (C and D) Microdissected synaptic sample, doublestained with rBTX (C) and the nuclear stain DAPI (D). Bars: (A) 1 mm;
(B) 200 m; (C and D) 100 m. (E) Southern analysis of two nonsynaptic
(lanes 1 and 2) and two synaptic (lanes 3 and 4) samples after reverse transcription and PCR amplification. Gel was stained with ethidium bromide
(EtBr) to verify equal loading. Blots were probed for transcripts known to
be synaptically enriched (AChR, AChE, PKARI [PKA], and MuSK) or
presumed to be uniformly distributed (cyclophilin [cycloph.] and GAPDH).

blotting for four transcripts known to be enriched in synaptic
areas (the AChR -subunit, acetylcholinesterase [AChE], the
protein kinase A RI subunit [PKARI], and the muscle specific kinase [MuSK]; references in Introduction), as well as two
broadly expressed genes (glyceraldehyde-3-phosphate dehydrogenase [GAPDH] and cyclophilin). Pairs of samples were
selected in which: (a) the synaptic sample was rich in products
amplified from the synaptic genes, (b) the nonsynaptic sample
contained little or none of these products, and (c) both samples
had nearly equivalent levels of the broadly expressed genes
(Fig. 1 E). Of 100 pairs analyzed, the nine that best fulfilled
these criteria were hybridized to Affymetrix Murine U74A, B,
and C GeneChips, which together contain 36,701 probe sets.
As a first test of the method, we calculated the synaptic
enrichment of the six transcripts for which there was the best
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to RNAs from synapse-free portions of muscle. This comparison
led to identification of several new synaptic transcripts, encoding membrane, cytoplasmic, cytoskeletal, and nuclear proteins.
In the second part of the paper, we describe LL5, a protein encoded by one of the synaptic RNAs we identified. LL5
was previously identified in a database search for proteins containing pleckstrin homology (PH) domains, which bind phosphoinositides on the inner leaflet of the plasma membrane
(Dowler et al., 2000). Subsequent analysis showed that this
binding is regulated by extracellular signals and that LL5 also
binds a cytoskeletal, actin-associated protein, filamin (Paranavitane et al., 2003), one form of which is concentrated at the
NMJ (Bloch and Hall, 1983; Shadiack and Nitkin, 1991). We
show here that LL5 is associated with the postsynaptic membrane at the NMJ, that it is concentrated at borders of the
postsynaptic domain as it develops, and that it regulates acetylcholine receptor (AChR) aggregation in this domain. We propose that LL5 is a regulated link in a multimolecular complex
that corrals AChRs in the postsynaptic apparatus.

Published April 25, 2005

Table I. Enrichment of known synaptic mRNAs in synaptic samples
Gene name

Exp. 1

Exp. 2

Exp. 3

Exp. 4

Exp. 5

Exp. 6

Exp. 7

Exp. 8

Exp. 9

Mean rank

Pooled rank

AChR1
AChR
AChR
MuSK
AChE
PKARI
Mean

20
3631
83
8801
8458
1046
3673

1051
4775
36
3624
14475
8579
5423

176
8096
80
30131
18126
3298
9985

4
265
5
47
3488
1571
897

50
565
18
1807
1062
329
639

16
874
88
405
743
208
389

10
11596
18
29
64
4957
2779

4496
3154
6
1490
4872
3250
2878

66
83
119
4271
6513
968
2003

654
3671
50
5623
6422
2690
3185

2
21
1
20
54
18
19

Probe sets for six synaptic genes were ranked each in microarray pairs by calculating ratio of signal in synaptic sample to that in extrasynaptic sample, and then
ranking ratios of all 36,701 probe sets. None of the mean rank orders (calculated for each chip or for each gene) are in the top 25, but when signals were pooled
and then ranked (see text), five out of six genes ranked in the top 25.

from each combination of the 36 (9  8/2) possible set of two
pairs, each of the 84 (9  8  7/3  2) possible sets of three
pairs, and so on. Results are shown in Fig. 2. The two lines enveloping the individual points show the best and worst rank orders that could be obtained; the central line shows the mean rank
order (Fig. 2). Three features of the graph are noteworthy. First,
as expected, the overall reliability of the rankings increases with
the number of replicates (Fig. 2, middle line). Second, even
though all pairs provide useful data, there is such great variability among them that the reliability of rankings varies manyfold
depending on which particular pairs are considered (Fig. 2, difference between top and bottom lines). Third, if one can prospectively identify control genes, it is possible to obtain more reliable
data from a subset of the pairs than from all of them (Fig. 2, bottom line). For example, the mean rank order of the six control
genes is 19 for all nine pairs, but 14 for the best six pairs.
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prior evidence of synaptic enrichment. Four of these (AChR,
AChE, PKARI, and MuSK) had been used for prescreening
by Southern analysis, but the other two (AChR and AChR)
had not. Enrichment of each transcript was calculated as the ratio of the synaptic to extrasynaptic expression levels (Table S1,
available at http://www.jcb.org/cgi/content/full/jcb.200411012/
DC1) and as the rank order of the synaptic/nonsynaptic ratios
(Table I). All but 1 of the 54 ratios (6 genes  9 pairs) were 1
(normalization set the mean ratio equal to 1), and all but the corresponding one rank order were above the mean of 18,350
(36,701/2). Both distributions were highly nonrandom (P
10 14; binomial test). Moreover, the geometric mean of ratios of
these six control genes and the arithmetic mean of their rank order (Table S1 and Table I, bottom row) were much higher than
expected by chance (P 0.03 for pair No. 3 and P 0.0006 for
all other pairs; computed using bootstrapping tests). Ratios and
rank orders for the transcripts that had been used for prescreening were not better than those that had not.
Although known synaptically enriched transcripts ranked
high in each GeneChip pair, only a small fraction of the
transcripts with high ratios or rank orders were likely to be
synaptically enriched, owing to method-derived noise and natural variation among samples. When we combined results
from multiple pairs, however, a dramatically different picture
emerged. The last column of Table I shows combined rankings
for all nine pairs for the six control genes (calculated as S1/E1 
S2/E2...S9/E9). The improved quality of the pooled data can
be seen by comparing it with the mean rank orders of genes for
the nine pairs taken individually. For example, the mean rankings for the AChR and  subunits are 50 and 654, respectively, whereas those for the pooled ranking are 1 and 2. We
also pooled results by dividing the sum of all synaptic scores
by the sum of all nonsynaptic scores (S1  S2...S9/E1  E2...E9)
and by using the significance analysis of microarrays (SAM)
method (Tusher et al., 2001), but these methods gave slightly
lower rank orders than the multiplicative method (unpublished
data) and were not used further. Our method of ranking genes
by geometric means of their ratio is equivalent to that independently proposed by Breitling et al. (2004), who also found that
nonparametric ranking could outperform the SAM method.
The availability of multiple chip pairs and validated control transcripts afforded the opportunity to ask how many replicates are needed to obtain reliable rank orders. To this end, we
calculated the mean rank order for the six control transcripts

Identification of novel synaptic
transcripts

We ranked the 36,701 probe sets from the “best” eight pairs of
samples (Table I; Exp. 3 was omitted based on the low ranking
of the six control genes) and asked how many of the top 25 represented transcripts enriched at synaptic sites. In some cases,
relevant data have been reported previously; for the others, we

Figure 2. Extent to which replicate sampling enhances reliable detection
of synaptic transcripts. Rank orders for six transcripts known to be synaptically enriched (AChR, AChR, AChR, AChE, PKARI, and MuSK) were
calculated for each of nine independent experiments, with the most synaptically enriched equal to 1 and the least equal to 36,701 (see Table I). The
mean rank order for all six transcripts was calculated for each combination
of the 36 (9  8/2) possible sets of two pairs, each of the 84 (9  8 
7/3  2) possible sets of three pairs, and so on. The two lines enveloping
the individual points show the best and worst rank orders that could be
obtained from a given number of pairs; central bars shows means.
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Table II. Transcripts with highest enrichment in synaptic compared
with extrasynaptic samples

assayed localization with in situ hybridization and/or quantitative RT-PCR (Fig. 3). As summarized in Table II, genes fell
into the following five categories.
Known synaptically enriched transcripts,

Of the six transcripts for which evidence of synaptic
localization is strongest (AChR, AChR, AChR, MuSK,
PKARI, and AChE; see Introduction), all but AChE ranked in
the top 25. A second probe set for AChR was also within the
top 25.
n

6.

Known

synaptically-enriched

proteins,

Nestin, an intermediate filament protein originally
identified in stem cells, is concentrated at the NMJ (Carlsson et
al., 1999; Vaittinen et al., 1999). We find that its RNA is also
enriched at synaptic sites.

n

1.

Genes expressed by Schwann cells, n

3.

Motor nerve terminals are ensheathed by Schwann cells, the
glia of the peripheral nervous system. Therefore, synapse-rich
358
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Ratio

UniGene (Mm.)

Gene Name

Validity

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

83.64
56.78
30.28
20.76
18.93
16.39
16.28
15.22
14.91
13.32
12.86
11.63
11.40
10.88
10.49
10.40
10.14
9.69
8.88
8.63
8.46
8.40
7.67
7.58
7.52

4980
4583
79127
291463
276739
29742
37644
66293
33268
5025
225050
16148
155708
23742
172931
211477
317642
124666
4980
32648
30039
2811
9986
295263
335452

AChR
AChR1
Dynein int. chain 1
Trifunctional enz.-
SOX10
CD24
rep seq
SDR2
Ssb4
PEA3
Unc53H3
MuSK
ERM
Nestin
rep seq
LL5
Serf2
NTA
AChR
unnamed
PKARI
AChR
MPZ
Cpg16
noncoding RNA

K-R
K-R
SY-?
–
SC
Sy-M
–
Sy-?
Sy-?
SC
Sy-M
K-R
K-R
K-P
–
Sy-M
–
Sy-M
K-R
Sy-?
K-R
K-R
SC
Sy-?
–

Rankings and ratios, calculated as in Table I and Table S1, respectively, are
shown along with UniGene number (http://www.ncbi.nlm.nih.gov) and gene
name. Last column classifies genes: K-R, known to be synaptic at RNA level;
K-P, known to be synaptic at protein level; SC, known to be selectively expressed
by Schwann cells; Sy-M, synaptic mRNA shown by in situ hybridization to be
expressed by muscle in this study; Sy-?, mRNA shown to synaptic by quantitative
PCR, but cell of origin unknown; –, no evidence for synaptic enrichment.

samples used for expression profiling contained Schwann cells,
whereas extrasynaptic samples, isolated from nerve-free regions, were Schwann cell-free. Therefore, we expected that
genes expressed by Schwann cells would be enriched in the
synaptic samples. Consistent with this expectation, three genes
known to be selectively expressed by Schwann cells were
within the top 25 transcripts: the transcriptional regulators
PEA-3 and SOX-10 and the myelin protein zero (Jessen and
Mirsky, 2002).
False positives, n
5. We obtained no evidence that transcripts expressed by five of the probe sets (Table
II, Nos. 4, 7, 15, 17, and 25) were enriched at synaptic sites.
Novel transcripts enriched in synaptic
10. Quantitative RT-PCR and/or in situ
hybridization confirmed synaptic enrichment of 10 gene products that had not previously been localized to the NMJ. As
noted above, these transcripts might be expressed by muscle fibers, Schwann cells, or perhaps other synapse-associated cells
(e.g., a specialized perisynaptic population of fibroblasts;
Gatchalian et al., 1989). For five of the mRNAs, in situ hybridization signals were too weak or diffuse to allow distinction
among these sites (Table II, Nos. 3, 8, 9, 20, and 24). For the
other five, however, in situ hybridization revealed a punctate
pattern of expression associated with individual muscle fibers
(Fig. 3, A and B); this finding was most consistent with local-

regions, n
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Figure 3. Verification of novel synaptic transcripts by whole mount in situ
hybridization and quantitative RT-PCR. (A and B) Neonatal diaphragm
was hybridized with probes for CD24 (A) or LL5 (B). RNA is concentrated at discrete sites identified as NMJs based on their number and position
and by histochemical staining of adjacent muscle pieces with rBTX or a
histochemical stain for AChE. Bar, 0.5 mm. (C) Quantitative RT-PCR of
synaptic and extrasynaptic samples. A broadly distributed transcript
(GAPDH, open squares) is present at similar levels in both samples,
whereas dynein intermediate chain (Table II, No. 3; filled squares) is
greater than sixfold enriched in the synaptic sample. Black and gray lines
show data from synaptic and extrasynaptic samples, respectively. Thick
line is the threshold value, used to calculate Ct (threshold cycle), from
which differences between samples were determined.

Rank

Published April 25, 2005

specific transcription (ERM), or our own data (LL5; see Figs.
7 and 8).
The 25 probe sets that we analyzed gave signals that were
7.5-fold higher in synaptic than in extrasynaptic regions of
muscle. Of the 36,701 probe sets queried, a total of 42, 70, 139,
and 424 showed greater than six-, five-, four-, and threefold
synaptic enrichment, respectively (Table S2, available at
http://www.jcb.org/cgi/content/full/jcb.200411012/DC1). Almost surely, the incidence of false positives will increase as the
enrichment decreases. Moreover, some of the true positives
may encode proteins expressed by nonmuscle cells, such as
Schwann cells or perisynaptic fibroblasts. Nonetheless, it
seems likely that the list in Table S2 includes many additional
novel synaptic components.
Coregulation of synaptically enriched
transcripts

Several RNAs previously shown to be enriched at synaptic
sites—notably the AChR, , and  subunits, N-CAM, and
MuSK—share two additional features: their abundance in muscle decreases as development proceeds and increases after denervation (Merlie et al., 1984; Covault et al., 1986; Goldman et
al., 1988; Valenzuela et al., 1995). We asked whether or not
RNAs encoding other components of the postsynaptic apparatus are regulated similarly.
First, we determined the synaptic enrichment of transcripts encoding basal lamina, plasma membrane, and cytoskeletal proteins concentrated in the postsynaptic apparatus
(Peters et al., 1994; Miner and Sanes, 1994; Altiok et al., 1995;
Moscoso et al., 1995a,b; Zhu et al., 1995; Patton et al., 1997;
Sanes and Lichtman, 1999). In addition to those transcripts
listed in Tables I and II, RNAs encoding AChR, AChR ,
rapsyn, ColQ, erbB3, utrophin, N-CAM, laminins 5, and collagen 3(IV) were enriched in the synaptic samples (Table III).
In contrast, RNAs encoding the basal lamina protein laminin
2, the membrane protein erbB4, and the cytoskeletal protein
syntrophin 2 were not appreciably enriched in synaptic
mRNA (unpublished data), even though their protein products
are concentrated at synaptic sites.
Second, we asked which synaptically enriched transcripts
are present at higher levels in embryonic (embryonic day 15) or
denervated muscles than in normal adult muscle. For this purpose, we generated new targets by conventional methods that
did not involve amplification. 76% of the synaptically enriched
transcripts queried (16/21) were up-regulated after denervation, and 81% (17/21) were down-regulated during development (Table III). Three genes identified in this study, NTA,
unc53H3, and LL5, share this pattern.
Synaptic genes are not, however, completely coregulated.
Some variations from the common pattern have been noted
previously, for example the postnatal up-regulation of AChR,
and the down-regulation of AChE after denervation (Sanes and
Lichtman, 1999). Another pattern is that of ERM RNA, which
changes little during development or after denervation. Synaptic nuclei acquire specialized properties during development
and maintain them in denervated muscle. Although AChR subunit genes are selectively transcribed by these nuclei, they are

LOCALLY TRANSLATED SYNAPTIC COMPONENTS • KISHI ET AL.

Downloaded from jcb.rupress.org on November 8, 2011

ization in the postsynaptic apparatus (Moscoso et al., 1995a,b),
although association with Schwann cells cannot be ruled out.
One of these gene products, LL5 (No. 16; Fig. 3 B), is described in detail below (see Figs. 4–6). The other four are described in the following paragraphs.
The first gene product, CD24 (No. 6), is a small, highly
glycosylated, membrane-associated protein. It has been studied
most intensively in the immune system but is also expressed in
the nervous system, where it has been implicated in the control
of neurogenesis and neurite outgrowth (Calaora et al., 1996; Shewan et al., 1996; Kleene et al., 2001; Belvindrah et al., 2002).
The second gene product, Unc53H3/neuron navigator
3/ POMFIL1 (No. 11; Coy et al., 2002; Maes et al., 2002; Merrill et al., 2002), is predicted, on the basis of its sequence, to be
a cytoplasmic, actin-binding adaptor protein. It is one of three
mammalian orthologues of Caenorhabditis elegans unc-53.
Unc 53 mutants exhibit defects in axon branching and muscle formation (Hekimi and Kershaw, 1993; Stringham et al.,
2002), and unc53H2-deficient mice show defects in sensory
acuity and optic nerve growth (Peeters et al., 2004).
The third gene product, ERM (No. 13), is a member of a
large family of “Ets-domain” transcriptional regulators (Sharrocks, 2001). Ets-domain proteins are believed to promote selective transcription of AChR subunit genes by synaptic nuclei
(Schaeffer et al., 2001). Attention has centered on the Etsrelated proteins GABP- and -, but both RNAs are present in
extrasynaptic as well as synaptic regions (Fromm and Burden,
1998; Schaeffer et al., 1998), suggesting that additional factors
are involved in limiting GABP-mediated transcription to specific sites. That Ets-domain factors function as heterodimers
makes it tempting to speculate that ERM plays such a role.
Consistent with this possibility, Hippenmeyer et al. (2002) recently published micrographs suggesting selective localization
of ERM RNA in synaptic regions of embryonic muscle.
Finally, NTA (No. 18) RNA encodes a 217–amino acid
protein conserved in several mammalian species (mouse, rat,
and human; UniGene identifiers are Mm 21836, Rn. 13571, and
Hs. 157779, respectively). This RNA begins just 200 bp 3 to
the last known exon of the AChE gene (Wilson et al., 2001), so
we have given its locus the working name “NTA” for “next to
AChE.” It is unclear whether it represents an alternative transcriptional product of the AChE locus or a distinct gene. Our
data are consistent with both possibilities: Northern analysis using an NTA-specific probe revealed transcripts of 1.2 and 3.8
kb in muscle, the former excluding and the latter including
AChE-derived sequences (unpublished data). The differential
regulation of NTA and AChE RNAs by innervation (see the following section) also implies the existence of distinct mRNAs.
In summary, of the top 25 genes from our microarray
analysis, the synaptic enrichment of 20 was validated by a second method (RT-PCR, in situ hybridization, or published immunohistochemical localization). Of these 20, at least five encode RNAs that are concentrated very near the NMJ but have
not previously been studied in the context of the NMJ. Remarkably, all five are plausible candidates for synaptic roles, based
on their chromosomal localization (NTA), roles in other neural
systems (Unc5h3 and CD24), known properties of synapse-
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Table III. Regulation of synaptic genes during development and after
denervation
Gene name

Synaptic/
extrasynaptic

Denervation/
adult

Embryonic/
adult

1
2
6
11
12
13
14
16
18
21
22
47
79
122
307
455
1728
2227
2845
4925
7374

AChR
AChR1
CD24
Unc53H3
MuSK
ERM
nestin
LL5
NTA
PKARI
AChR
AChE
collagen 3(VI)
ColQ
utrophin
AChR
AChR1
NCAM
laminin 5
rapsyn
ErbB3

83.64
56.78
16.39
12.86
11.63
11.40
10.88
10.40
9.69
8.46
8.40
5.78
4.82
4.14
3.28
2.95
2.13
1.99
1.88
1.61
1.44

0.28
25.35
1.93
1.35
4.89
0.93
0.41
1.95
1.49
1.66
2.42
0.09
1.08
1.15
4.76
1.10
6.16
1.77
1.35
0.50
2.83

0.04
3.58
0.34
3.17
7.58
0.47
4.03
4.04
2.57
1.08
7.12
1.95
1.58
1.91
2.75
19.36
1.09
0.95
3.40
1.57
8.69

Synaptic enrichment of transcripts previously known to encode synaptic proteins
was determined as in Table S1; those with rankings in the top 20% are listed,
along with new genes identified in this study. Changes in abundance during
development and after denervation were assessed with duplicate microarrays.

also transcribed by extrasynaptic nuclei during development
and after denervation. Expression of a gene involved in controlling synapse-specific transcription might be expected to remain more confined to synaptic nuclei than expression of the
genes it regulates. Our results are consistent with the idea that
ERM is one such gene.
Synaptic localization of LL5

The rationale for our screen was that RNAs concentrated in
synaptic areas encode proteins concentrated at synaptic sites.
This idea was plausible but unproven, in that all synaptically
enriched RNAs described to date were identified because their
protein products were already known to be synaptic components. Therefore, we asked whether or not a novel gene identified in our screen, LL5, encoded a synaptic component.
LL5 is an 160-kD protein containing two predicted
coiled-coil domains, a serine-rich region predicted to contain
multiple protein kinase C phosphorylation sites, and a phosphoinositide-binding module called a PH domain. Many PH
domains selectively bind 3-phosphorylated phosphoinositides
that are generated in the inner leaflet of the plasma membrane
by phosphatidylinositol 3-kinase (PI3K); therefore, they serve
to recruit signaling proteins to the membrane in response to
PI3K activation (Lemmon and Ferguson, 2000). Paranavitane
et al. (2003) showed that LL5 binds both phosphatidylinositol
(3,4,5)-triphosphate and a cytoskeletal adaptor protein, -filamin, and that activation of PI3K regulates its association with
the membrane. Two partial homologues of LL5 are present
in the mouse genome: LL5, which binds phosphoinositides
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Figure 4. Structure and synaptic localization of LL5. (A) Structures of
LL5 and two homologues, LL5 and LL5 . The percentage of amino acid
identity of conserved domains is shown; amino termini of the three gene
products are dissimilar. FHA, forkhead-associated domain; Ser, serine-rich
region; COIL, coil-coil domain; PH, pleckstrin homology domain. (B–D)
Longitudinal sections of adult muscle stained with mAb to LL5 (low magnification, B; high magnification, D) or control antibody of the same isotype
(C) plus rBTX. LL5 is colocalized with AChRs. (E) Cross section of an
adult rat NMJ showing LL5 concentrated in the depths of junctional folds
and between AChR-rich areas at the crests of folds. (F) Synaptic concentration
and colocalization were evident by prenatal day 4. (G) C2 myotubes
were treated with agrin to induce AChR clusters, and then stained with
anti-LL5 and rBTX. LL5 is concentrated at AChR-rich clusters. Bars: (B and C)
100 m; (D) 20 m; (E and F) 5 m; (G) 10 m.

(Dowler et al., 2000) but has not been studied further, and a
novel sequence that we found by database searching and call
LL5 . The three members of the LL5 family all have two
coiled-coiled domains and a PH domain, but strong homology
is restricted to their carboxy termini; their amino termini are divergent in both sequence and domain structure (Fig. 4 A). To
date, no physiological role has been reported for any member
of the LL5 family.
To ask if LL5 is synaptically localized, we raised monoclonal antibodies to a region with low homology to LL5 and
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Figure 5. Synaptic localization of LL5 requires its PH domain. Muscles
were electroporated with the indicated constructs. 4 d later, fibers were
fixed, teased, and stained with rBTX. (A) GFP-LL5 colocalizes with AChRs
at the NMJ. (B and C) A fusion protein lacking the carboxy-terminal PH
domain (GFP-LL5-PH [B]) and GFP alone (C) are diffusely distributed.
Bar, 20 m.

(see Materials and methods) and used them to stain longitudinal sections of adult mouse and rat muscles. NMJs were selectively stained (Fig. 4, B–D), although nerve bundles and fibroblasts were also LL5-positive (not depicted). Similar results
were obtained with two other antibodies to LL5, whereas control antibodies of the same isotype did not stain NMJs. Highpower views of cross sections suggested that the distribution of
AChRs and LL5 was not identical within NMJs: AChRs are
concentrated at the crests of junctional folds (Sanes and Lichtman, 2001), whereas levels of LL5 were highest in the depths
of junctional folds and between AChR-rich regions (Fig. 4 E).
Substantial colocalization of LL5 and AChRs was evident by
P4 (Fig. 4 F). LL5 was also colocalized with AChR-rich
patches in cultured myotubes (Fig. 4 G).
These results demonstrate an association of LL5 with
the postsynaptic membrane of the NMJ. To ask if the PH domain mediates this association, we fused GFP to LL5 or to a
mutant LL5 from which the PH domain had been deleted
(LL5PH). Expression plasmids encoding GFP-LL5, GFPLL5PH, or GFP alone were electroporated into mouse anterior tibialis muscles. By 4 d after electroporation, GFP was
colocalized with AChRs in muscle fibers expressing GFPLL5 (Fig. 5 A; n
10). In contrast, GFP immunofluorescence was diffuse and cytoplasmic in fibers from muscles that
had been transfected with GFP-LL5PH or GFP alone (Fig.
5, B and C; n 10 each). Likewise, GFP-LL5 but not GFPLL5PH localized to AChR-rich clusters in cultured myotubes (unpublished data). Thus, its PH domain is essential for
targeting LL5 to the NMJ. In contrast, fusion of GFP to isolated PH domains did not localize to AChR clusters in myotubes (unpublished data), indicating that although the PH domain is necessary for localization it is not sufficient.

Figure 6. LL5 is associated with borders of developing AChR clusters.
C2 myotubes were cultured on a laminin substrate to induce development
of complex, branched AChR aggregates, and then double-stained with
anti-LL5 and rBTX. (A) LL5 is colocalized with AChRs in simple plaques
but concentrated at the circumference of the clusters. (B and E) Peripheral
distribution of LL5 becomes more marked as clusters become perforated
and then branched. Bracketed region in E is shown at higher magnification
in F. (C and D) In some cases, LL5 is most concentrated at the borders
of the perforations that transform plaques into annuli and then into
branched aggregates. (F) Within aggregates, AChRs and LL5 have
complementary distributions. (G) High magnification view of an NMJ from
a P7 mouse (Fig. 4 F) showing similar complementarity in vivo. Bars: (A–E)
10 m; (F and G) 1 m.

Role of LL5 in AChR clustering

For further analysis of LL5 localization and function, we
used a culture system in which myotubes form elaborate,
branched AChR aggregates that resemble adult NMJs in several respects. The aggregates form on the substrate-facing
surface, and can thus be imaged in a single plane; and they
form from simple plaques in a series of steps resembling
those that transform the embryonic NMJ into the adult structure in vivo (Kummer et al., 2004). They are therefore useful
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for following developmental changes in LL5 distribution
that could not be discerned in vivo.
LL5 was associated with AChR-rich plaques in this system throughout their evolution, but its distribution differed systematically from that of AChRs. In simple plaques, AChRs were
uniformly distributed, whereas LL5 was concentrated around
the circumference (Fig. 6 A). Subsequently, as plaques became
perforated at their centers, the peripheral distribution of LL5
became more marked (Fig. 6 B). In some cases, LL5 also
rimmed the outer circumference of the perforations that transform plaques into annuli and then into branched structures (Fig.
6, C and D). The tendency of LL5 to concentrate at the periphery persisted in branched aggregates but was less striking (Fig. 6
E). Within aggregates, LL5 and AChRs were often distributed
in complementary patterns (Fig. 6 F); the distribution of LL5 is
reminiscent of that of vinculin and dystrophin (Bloch and Pumplin, 1988; Dmytrenko et al., 1993). Likewise, LL5 and AChRs
appeared to have complementary distributions at developing
NMJs in vivo (Fig. 6 G), as well as at adult NMJs (Fig. 4 E), although the more favorable geometry of myotube cultures made
details of the localization more readily appreciated in vitro.
To find whether or not LL5 plays a role in AChR clustering, we used RNAi to suppress its expression in myotubes.
Two of four sequences tested effectively suppressed LL5 expression in heterologous cells (Fig. 7 A and see Materials and
methods). These sequences were used to generate expression
vectors, which were introduced into muscle cells. Both vectors
decreased the level of endogenous LL5 by 40–50% and the
frequency of AChR clustering by 50% compared with untreated cultures, whereas control vectors had no significant effect (Fig. 7, B and C; and not depicted). None of the RNAi vectors had any apparent effect on cluster size or shape.
Given the low transfection efficiency that we and others
have noted for muscle cells, we were surprised that LL5
RNAi suppressed AChR clustering in so many myotubes.
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Therefore, we assayed transfection efficiency with GFP. Endogenous GFP fluorescence was detectable in only 10% of
myotubes, but immunostaining with anti-GFP revealed low
levels of expression in an additional 50% of myotubes (Fig. 7
D). We suggest that RNAi vectors are also expressed at low
levels in most myotubes, and that these levels are sufficient to
suppress LL5 function because RNAi acts catalytically. Consistent with this idea, the 40–50% decrease in total LL5 levels
in the myotube cultures implies that levels are decreased by
65–80% in the transfected myotubes.
As a second approach to assessing the function of LL5,
we overexpressed GFP-LL5 in myotubes. The fusion protein
was associated with AChR aggregates when it was expressed at
modest levels (unpublished data; levels assessed by staining
with anti-LL5, and comparing to endogenous levels in controls). In contrast, GFP-LL5 was diffusely distributed in myotubes that expressed high levels of fusion protein, and few
AChR aggregates were present in these myotubes (Fig. 8 A).
Instead, AChRs in these myotubes were distributed diffusely
and in small patches (Fig. 8 A). No perturbations were observed in myotubes expressing GFP alone, the GFP-LL5PH
fusion protein, or the GFP-PH fusions (Fig. 8, B–D; and not depicted), indicating that the effects of the LL5 were specific.
However, lacking another PH domain–containing protein that
localizes to AChR clusters, we cannot rule out the possibility
that the effects of overexpression result from a nonphysiological perturbation of the AChR-rich domain.

Discussion
Although much is known about the molecular architecture of the
synapse, it is clear that additional components remain to be discovered. To identify some of them, we exploited the finding that
all of 10 mRNAs previously reported to be concentrated in synaptic regions of muscle fibers encode components of the postsyn-
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Figure 7. LL5 is required for AChR clustering.
(A) COS cells were cotransfected with GFPLL5 plus control duplex VIII siRNA (left), LL5RNAi#1 (center), or LL5-RNAi#2 (right), and
then examined for GFP fluoresence. RNAi#1
and #2 suppressed GFP-LL5 expression. (B and
C) Myotubes cultured on laminin (Fig. 6) were
transfected with the indicated RNAi vectors, or
control RNAi vector, fused to form myotubes,
and then stained with rBTX. Both LL5 RNAi’s
decreased the number of AChR aggregates,
whereas control RNAi (a sequence that effectively suppressed GFP) had no effect. (C) Examples are shown in B and data from one experiment are graphed (C; 15–10 microscope
fields were counted per culture). The difference between LL5 RNAi and either control
is significant at P
0.001 by t test. Similar
results were obtained in two additional experiments. Western blots of myotube lysates, using
anti-LL5 antibody 7E3, are shown in C
(bottom). Densitometry showed that RNAi#1
and #2 decreased LL5 protein levels by 40–
50% compared with mock-transfected and
control RNAi-transfected cultures. Error bars
show mean  SEM. (D) GFP-transfected myotubes were stained with anti-GFP to show high transfection efficiency. Only the brightest myotubes would
appear positive for endogenous GFP fluorescence. Inset shows mock-transfected myotubes stained with anti-GFP. Bar, 100 m.
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aptic apparatus at the NMJ (Merlie and Sanes, 1985; Goldman
and Staple, 1989; Jasmin et al., 1993, Moscoso et al., 1995b;
Valenzuela et al., 1995; Imaizumi-Scherrer et al., 1996; for reviews see Sanes and Lichtman, 1999, 2001; Chakkalakal and Jasmin, 2003). Therefore, we used microarray-based expression
profiling to seek additional synaptic RNAs. By combining microdissection, controlled amplification, sample prescreening, and
multiple replicates, we reduced the false positive rate to 20% for
the top tier of 25 genes, validated 10 novel RNAs enriched in synaptic areas, and provided 200 additional candidates.
Our analysis demonstrates the power of the Tietjen et al.
(2003) method for expression profiling of tiny samples and provides some guidelines for its use. In particular, our data directly
demonstrate that the amplification method generates high amplitude noise, which obscures enrichment of transcripts. In fact,
most exceptionally high and low values obtained from any single
GeneChip represent noise. Because this noise is more or less random, however, it is efficiently diluted when data sets are pooled,
facilitating detection of genes that are consistently enriched,
even if the degree of enrichment is modest.
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Figure 8. Overexpression of LL5 perturbs
AChR clustering. Myoblasts cultured on laminin
(Fig. 6) were transfected with the indicated
constructs, fused to form myotubes, and then
stained with rBTX. (A) Few large AChR clusters
are present in myotubes that overexpress GFPLL5; instead, receptors are present diffusely
and in small patches (arrows). (B and C)
Forced expression of GFP (B) or a GFP-LL5
fusion protein lacking the PH domain (GFPLL5-PH; C) has no effect on the frequency of
aggregation. Bar, 100 m. (D) Percent of
transfected (strongly fluorescent) or untransfected myotubes with complex AChR aggregates. 80 myotubes were analyzed per condition: 40 in each of two separate experiments.
Difference between GFP-LL5 and each other
condition is significant at P
0.001. Error
bars show mean  SEM.

We also used conventional expression profiling to show
that greater than three fourths of the known and novel synaptic
RNAs are coregulated during development and after denervation, suggesting the existence of a common regulatory program. One cis-element critical for synaptic expression is the
N-box, a site that binds Ets-domain transcription factors; such
sites are already known to play roles in the synaptic transcription of genes encoding AChR subunits, AChE, and utrophin
(Koike et al., 1995; Schaeffer et al., 2001). Cis-elements called
E-boxes, which bind basic helix-loop-helix factors, have been
implicated in down-regulation during development and up-regulation after denervation. Many genes selectively transcribed in
synaptic nuclei may share a set of such cis-elements, as envisioned for members of “synexpression groups” (Niehrs and
Pollet, 1999). However, synaptic genes are not completely coregulated. Reasons for the exceptions are unknown, but we
speculate that expression of genes involved in regulating synapse-specific transcription might be more confined to synaptic
nuclei during development and after denervation than expression of the genes they regulate. ERM may be one such gene.
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Materials and methods
Microarray analysis
To isolate NMJs, diaphragms of C57B1 6J mice were incubated in ice-cold
PBS containing 10 g/ml rBTX (Molecular Probes) for 5 min to stain NMJs,
and then washed with PBS. Clusters of 20 closely spaced NMJs were located with a fluorescent dissecting stereomicroscope (model SZX12; Olympus) and cut out using forceps and a micro-knife. Synapse-free samples of
equivalent size were obtained from each muscle and processed in parallel.
These samples were used for cDNA synthesis and PCR amplification as described by Dulac and Axel (1995). The cDNAs were assayed by Southern
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blotting using the following probes: GAPDH (GenBank/EMBL/DDBJ accession no. M32599; nt 529–1228), cyclophilin A (GenBank/EMBL/DDBJ
accession no. X52803; 22–708), AChR (GenBank/EMBL/DDBJ accession no. M17640; 1148–1825), AChE (GenBank/EMBL/DDBJ accession
no. X56518; 1372–2062), MuSK (GenBank/EMBL/DDBJ accession no.
U37709; 2626–3299), PKARI (GenBank/EMBL/DDBJ accession no.
BC003461; 2591–3279). Based on results of Southern analysis, probes
were prepared from nine pairs of samples (six from adult and three from P4
animals) by minor modifications of the methods of Tietjen et al. (2003). In
brief, PCR products were reamplified, purified, digested with EcoRI, purified
twice on CHROMA SPIN-200 Columns (CLONTECH Laboratories, Inc.),
fragmented with RQ1 DNase (Promega) for 13 min at 37C, and biotinylated with Biotin-N6-ddATP (NEN Life Science Products) and terminal transferase (Invitrogen) for 90 min at 37C. The targets were hybridized to GeneChip arrays (Murine U74A, B, and C; Affymetrix, Inc.), which were then
processed as described by Lockhart et al. (1996).
For analysis of gene regulation, we compared lower leg muscles
from day 15 embryos, lower leg muscles from adults 4 d after unilateral
section of the sciatic nerve, and contralateral innervated muscles from the
same mice. Total RNA was isolated with Trizol Reagent (Invitrogen) and
RNeasy Mini Kit (QIAGEN). RNA was converted to double-stranded
cDNA with an oligo(dT) primer containing a T7 promotor and used for
synthesis of biotinylated cRNA using a Bioarray HighYield Kit (Enzo). The
cRNA targets were fragmentated as described previously (Lipshutz et al.,
1999), and then hybridized to GeneChips as described for cDNA. Results
from duplicate samples were averaged.
Data were analyzed with Affymetrix Microarray Suite 5.0 software
package. The numerical signal intensity for each probe set was used for
further calculation in Microsoft Excel and R (www.r-project.org). The SAM
program (Tusher et al., 2001) was used at the threshold value of 0.05.
Quantitative RT-PCR
Mouse diaphragms were stained with rBTX as in Microarray analysis and
divided into synapse-rich and -free segments (Merlie and Sanes, 1985). Total RNA was extracted, and 1-g aliquots were used for cDNA synthesis.
Products were used for quantitative RT-PCR using the TaqMan 7700 Sequence Detection System (PerkinElmer) and SYBER-GREEN dye (Applied Biosystems) as described previously (Wittwer et al., 1997; Morrison et al.,
1998). Levels of GAPDH RNA were used for normalization. Assays were repeated on two independently prepared samples, and each sample was assayed in duplicate.
Antibody production
A fragment of LL5 corresponding to aa 418–760 was fused to a polyhistidine epitope tag, expressed in Escherichia coli, purified with Ni-NTA
Spin Kit (QIAGEN), and used to immunize BalbC mice. Hybridomas were
produced by standard methods, and their products were assayed by
ELISA, using immobilized immunogen, and by immunostaining of COS
cells transfected with a GFP-LL5 fusion. Three mAbs (1H12, 6B9, and
7E3) were subcloned.
Evidence that these antibodies specifically recognize LL5 is as follows: (a) the antibodies stain COS cells transfected with LL5 but not untransfected cells (Fig. S1 B, available at http://www.jcb.org/cgi/
content/full/jcb.200411012/DC1). (b) Antibody staining patterns of untransfected muscle fibers match GFP fluorescence patterns in muscle fibers
transfected with the LL5-GFP fusion (compare Figs. 4 B and 5 A). (c)
There is a similar correspondence for cultured muscle cells. (d) Two of the
three antibodies (7E3 and 1H12) detect a single band on immunoblots of
C2 myotube lysates (Fig. S1 A). This is the expected size for LL5. Results
using antibody 1H12 (IgG1 subclass) are shown here, but similar results
were obtained with 6B9 and 7E3.
Histology
Whole mount in situ hybridization was performed as described by Wilkinson and Nieto (1993) using digoxygenin-labeled cRNA probes. Digoxygenin was detected with alkaline phosphatase-conjugated anti-digoxygenin antibody (Roche), and signal was developed with NBT plus BCIP.
For immunohistochemistry, mouse or rat muscles were fixed in 1%
PFA, sunk in 30% sucrose/PBS, frozen, and sectioned at 10 m in a cryostat. Sections were stained sequentially with anti-LL5 and a mixture of
Alexa 488–conjugated secondary antibody and rBTX or Alexa 596–BTX
(Molecular Probes).
Electroporation in vivo
Mouse LL5 cDNA was obtained from American Type Culture Collection
(IMAGE clone 6405379). Full-length and PH domain–deleted coding sequences (lacking aa 1194–1302) were amplified by RT-PCR and ligated
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All five of the novel RNAs that we showed to be enriched
at or near synaptic sites by in situ hybridization (NTA, Unc5h3,
CD24, ERM, and LL5) are reasonable candidates for synaptic
roles. Here, we focused exclusively on one of them, LL5.
LL5 had previously been shown to bind phosphoinositides
and filamin (Dowler et al., 2000; Paranavitane et al., 2003), but
its localization and physiological function were unknown. We
found that LL5 is a component of the postsynaptic apparatus,
thereby validating our overall strategy. Moreover, detailed
analysis of localization as well as loss- and gain-of-function
analyses showed that LL5 is part of the machinery required
for aggregation of AChRs.
The mechanism by which LL5 affects AChR aggregation
remains to be explored, but some clues exist: (a) LL5 is most
highly concentrated in AChR-poor regions directly adjacent to
AChR-rich regions (edges of clusters and interstices between microaggregates, in vitro and in vivo: Fig. 4 E; and Fig. 6, F and G).
(b) Its association with the postsynaptic membrane is mediated
by its phosphoinositide-binding PH domain (Fig. 5). (c) It binds
to a cytoskeletal component, filamin (Paranavitane et al., 2003),
one form of which is itself colocalized with clustered AChRs in
myotubes (Bloch and Hall, 1983; Shadiack and Nitkin, 1991). (d)
It can reorganize the cytoskeleton in response to extracellular signals that regulate its association with the membrane (Paranavitane et al., 2003). (e) AChR-rich and -poor regions within AChR
aggregates differ in their lipid composition (Pumplin and Bloch,
1983; Scher and Bloch, 1991; Barrantes, 2002). Together, these
data suggest a model in which LL5 “corrals” AChRs by forming a dynamic link between specific lipids and the AChR-associated cytoskeleton; the link would remodel as AChR clusters grow
or change in shape, and might even help direct shape changes.
In this model, corrals would be unable to form when LL5
is absent, impeding clustering, whereas overexpression of LL5
might inhibit AChR aggregation by preventing microaggregates
from coalescing into larger clusters. Alternatively, when LL5 is
present in excess, some molecules might bind the cytoskeleton
and others the membrane, disrupting the corraling complex and
leading to a phenotype similar to that seen when LL5 levels are
decreased. The latter explanation is similar to that postulated for
rapsyn, another protein associated with the cytoplasmic face of
the postsynaptic membrane: no AChR clusters form in the absence of rapsyn (Gautam et al., 1995), but overexpression also
inhibits clustering (Yoshihara and Hall, 1993; Han et al., 1999).
One way to elucidate LL5’s mechanism of action will be to
identify the signals that affect its localization or binding capacity
and to ask if it interacts with intracellular pathways already implicated in AChR clustering (Jones and Werle, 2000; Weston et
al., 2000; Luo et al., 2002, 2003; Finn et al., 2003).
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to the BglII–SalI site of pEGFP-C1 vector (CLONTECH Laboratories, Inc.).
Inserts were sequenced. Plasmids were introduced into tibialis muscles of
P10 mice by electroporation as described by Grady et al. (2003). 4 d after electroporation, muscles were dissected under a fluorescent stereomicroscope, fixed in 4% PFA, counterstained with BTX, and imaged with a
confocal laser scanning microscope (model FV500; Olympus) using a
100 oil objective (NA 1.40).

Online supplemental material
Fig. S1 shows evidence for specificity of anti-LL5 antibodies. Table S1
shows the ratio of synaptic to extrasynaptic signal for each synaptic gene
from each microarray experiment. These ratios were then ranked to give
the values presented in Table I. Table S2 shows transcripts enriched
greater than threefold in synaptic compared with extrasynaptic samples.
Rankings and ratios, calculated as in Table I and Table S1, respectively,
are shown, along with UniGene number (http://www.ncbi.nlm.nih.gov)
and gene name. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200411012/DC1.
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